Tesamorelin Peptide Vial
+99% Purity cGMP Certified COA Every Batch
Peptide Vial

Tesamorelin Peptide Vial

4.9 (47 reviews)

Stackpure provides Tesamorelin Peptide Vial for HIV-associated lipodystrophy research, visceral fat reduction, and GHRH pharmacology studies. This research-grade peptide vial is an FDA-approved synthetic analogue of GHRH (transglutaminase-stabilised) that stimulates pulsatile GH release, preferentially reducing visceral adipose tissue (VAT) via IGF-1 independent mechanisms. Produced to +99% purity (HPLC verified), cGMP-certified, with a Certificate of Analysis available every batch.

For in vitro research use only. Not for human consumption. Not approved by the FDA. Not a drug, medicine, or supplement.

In Stock · Ships 1–3 days
$29.24
USD · Research pricing
1
Build a Stack
Format Peptide Vial
Purity +99% (HPLC verified)
Certification cGMP-certified facility
Certificate COA every batch, see testing standards on the Lab Testing page →
Certificate of Analysis, every batch
Product Tesamorelin Peptide Vial
Analytical Method HPLC / ESI-MS
Purity Standard +99%
Testing Party Independent third-party lab

Your batch's actual Certificate of Analysis is available on request with your order and batch number, usually within 24 hours. Full testing standards on the Lab Testing page.

Tesamorelin Peptide Vial is a research-grade peptide vial supplied by Stackpure for laboratory investigation. Tesamorelin is studied in the context of athletic performance, muscle hypertrophy, and physical endurance. Each unit is manufactured in a cGMP-certified facility and verified to +99% purity by HPLC analysis before dispatch.

What Is Tesamorelin?

Tesamorelin is a compound that has attracted significant interest in preclinical research examining athletic performance, muscle hypertrophy, and physical endurance. Scientists investigating Tesamorelin have worked to characterise its mechanisms, receptor interactions, and downstream biological effects across multiple in vitro and animal model systems.

Stackpure provides Tesamorelin Peptide Vial for researchers requiring verified, traceable material. Supplied as a lyophilised powder vial, this format offers maximum stability and flexibility for laboratory reconstitution. Researchers may also be interested in Tesamorelin Nasal Spray, which provides the same compound in an alternative format.

this peptide vial Research Applications

Preclinical studies involving this peptide vial have explored the following areas:

  • Growth hormone axis: Research has examined interactions with GHRP and GHRH pathways, with implications for GH pulsatility studies.
  • Lean mass research: Preclinical investigations have explored anabolic signalling and protein synthesis pathways relevant to muscle biology.
  • Endurance and fatigue: Studies have assessed mitochondrial efficiency and oxidative capacity in models of prolonged physical exertion.

These directions reflect the broad scientific interest in Tesamorelin and the growing body of literature examining its potential applications in research contexts.

Stackpure's peptide vial Quality Standards

Every this peptide vial supplied by Stackpure is held to rigorous analytical standards. Researchers choosing Stackpure peptide vial receive material that has been independently verified for identity, purity, and potency. Quality documentation includes a Certificate of Analysis (COA) for every production batch, providing full analytical transparency.

  • Purity: +99% by HPLC analysis
  • Facility: cGMP-certified manufacturing
  • Testing: Identity, purity, and potency verified per batch
  • Documentation: COA available for every order

This analytical rigour ensures that researchers working with Stackpure's peptide vial can maintain experimental consistency and reproducibility across studies.

Research Use Disclaimer

Independent Lab Verification

Stackpure works with independent, accredited third-party laboratories, including Vanguard Laboratory (ISO 17025:2017-accredited, A2LA Certificate #6377.01.01), to verify compound identity and purity. A Certificate of Analysis is included with every order.

this peptide vial from Stackpure is supplied strictly for in vitro research and laboratory purposes. This material is not approved for human or veterinary use and is not intended to diagnose, treat, cure, or prevent any condition. All research involving this peptide vial must be conducted in accordance with applicable institutional, ethical, and regulatory guidelines. For research use only.

Working with the lyophilized vial

  • Supplied as a freeze-dried powder, which keeps the compound stable until it is needed.
  • Requires reconstitution with a suitable diluent such as bacteriostatic water before use in a protocol.
  • Unopened vials are kept cold and away from light. Once reconstituted, solutions are kept refrigerated and used within the window set by your protocol.
  • Reconstituted concentration depends on the diluent volume you choose, so the same vial supports different working concentrations.

Other formats of Tesamorelin

FormatPrice (USD)
Tesamorelin Pre-Mixed Peptide $34.57 View
Tesamorelin Nasal Spray $38.14 View

Research Questions

What is Tesamorelin Peptide Vial used for in research?

this peptide vial is a research-grade peptide vial studied for HIV-associated lipodystrophy research, visceral fat reduction, and GHRH pharmacology studies. It acts as an FDA-approved synthetic analogue of GHRH (transglutaminase-stabilised) that stimulates pulsatile GH release, preferentially reducing visceral adipose tissue (VAT) via IGF-1 independent mechanisms. All findings are from pre-clinical in vitro and animal studies; it is not approved for human use.

How does Tesamorelin Peptide Vial work?

this peptide vial is an FDA-approved synthetic analogue of GHRH (transglutaminase-stabilised) that stimulates pulsatile GH release, preferentially reducing visceral adipose tissue (VAT) via IGF-1 independent mechanisms. This mechanism has been characterised in multiple pre-clinical studies, with particular focus on HIV-associated lipodystrophy research outcomes.

What research dosage is used for Tesamorelin Peptide Vial?

FDA-approved dose: 2 mg/day subcutaneous injection; research confirms 15–20% VAT reduction over 26 weeks. All dosage information is from pre-clinical or research contexts only. this peptide vial is sold exclusively for research use and is not approved for human consumption.

How does Tesamorelin Peptide Vial compare to related research compounds?

this peptide vial is frequently studied alongside CJC-1295 and Sermorelin for GHRH analogue comparison; HGH Fragment 176-191 for fat loss comparison. Its FDA-approved GHRH analogue classification distinguishes its mechanism from these alternatives, making it suitable for pathway-specific research protocols.

Where can I buy Tesamorelin Peptide Vial for research purposes?

Stackpure supplies this peptide vial as a research-grade peptide vial with +99% purity (HPLC verified), cGMP certification, and a Certificate of Analysis. Orders ship to the US, UK, Canada, and Australia. It is sold for in vitro research use only.

What does the Certificate of Analysis verify for Tesamorelin Peptide Vial?

A Certificate of Analysis (COA) reports identity (confirming the compound is what it's labeled as, via HPLC-UV/VIS matched against a reference standard) and assay/content (the measured purity percentage). this peptide vial is tested through independent third-party laboratory analysis, including work performed by Vanguard Laboratory (ISO 17025:2017-accredited, A2LA Certificate #6377.01.01), which is what verifies a batch matches its labeled specification rather than relying on a purity claim alone.